SL Friedman - Gastroenterology, 2008 - Elsevier Substantial improvements in the treatment of chronic liver disease have
accelerated interest in uncovering the mechanisms underlying hepatic fibrosis
and its resolution. Activation of resident hepatic stellate cells into ... Cited by 113 - Related articles - BL Direct - All 34 versions
M Friedrich–Rust, MF Ong, S Martens, C … - Gastroenterology, 2008 - Elsevier Background & Aims: Transient elastography has been studied in a multitude of
liver diseases for the staging of liver fibrosis with variable results. A
meta-analysis was performed to assess the overall performance of transient ... Cited by 62 - Related articles - All 31 versions
BJ Veldt, W Chen, EJ Heathcote, H … - Long-term clinical outcome of treatment for chronic … - publishing.eur.nl Chapter 9 Increased risk of hepatocellular carcinoma among patients with
hepatitis C cirrhosis and diabetes mellitus Bart J. Veldt1, Wendong Chen2, E.
Jenny Heathcote2, Heiner Wedemeyer3, Juerg Reichen4, W. Peter Hofmann5, 7, ... Cited by 23 - Related articles - View as HTML - BL Direct - All 5 versions
T Poynard, M Colombo, J Bruix, E Schiff, R … - Gastroenterology, 2009 - Elsevier This prospective, international, multicenter, open-label study evaluated
efficacy and safety of peginterferon alfa-2b (1.5 μg/kg/wk) plus weight-based
ribavirin (800–1400 mg/day) in 2333 chronic HCV-infected patients with ... Cited by 18 - Related articles - All 2 versions
AS Lok, LB Seeff, TR Morgan, AM di … - Gastroenterology, 2009 - Elsevier One thousand five patients (mean age, 50.2 years; 71% male; 72% white race) were
studied; 59% had bridging fibrosis, and 41% had cirrhosis. During a median
follow-up of 4.6 years (maximum, 6.7 years), HCC developed in 48 patients ... Cited by 13 - Related articles - All 2 versions
- ►annals.org [PDF] V Mallet, H Gilgenkrantz, J Serpaggi, V … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: The effect of regression of cirrhosis in chronic hepa- titis C is
unknown. ... Objective: To evaluate the relation between regression of
cirrhosis and clinical outcome in patients with chronic hepatitis C after ... Cited by 11 - Related articles - All 7 versions
SL George, BR Bacon, EM Brunt, KL … - Hepatology, 2009 - umcn.nl One hundred fifty patients with sustained virologic response (SVR) after
treatment of chronic hepatitis C were enrolled in a long-term clinical follow-up
study; patients were followed for 5 years for liver-related outcomes and ... Cited by 10 - Related articles - View as HTML - All 4 versions
DR Nelson, GL Davis, I Jacobson, GT Everson, … - Clinical Gastroenterology and Hepatology, 2009 - Elsevier In early May 2008, a panel of 11 nationally renowned hepatologists assembled to
investigate existing clinical controversies in hepatitis C management. The
purpose of this hepatitis C virus (HCV) Council was to critically review ... Cited by 8 - Related articles - All 2 versions
MW Welker, S Zeuzem - Hepatology, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 8 - Related articles - All 2 versions
- ►oxfordjournals.org JM Llovet, A Lok - JNCI Journal of the National Cancer Institute, 2008 - jnci.oxfordjournals.org Hepatocellular carcinoma (HCC) is one of the most common causes of
cancer-related death behind only lung and colon cancers (1) and the principal
cause of death among cirrhotic patients (2). The incidence of HCC is ... Cited by 6 - Related articles - All 5 versions
